FrancophonIA/ELRC3.0 huggingface dataset:
English: In diabetic hypertensive patients with microalbuminuria and normal renal function, orthostatic dizziness and orthostatic hypotension were reported in 0.5 % of the patients (i.e., uncommon) but in excess of placebo.
Croatian: U bolesnika koji boluju od hipertenzije i šećerne bolesti s mikroalbuminurijom, uz normalnu bubrežnu funkciju, prijavljene su ortostatska omaglica i ortostatska hipotenzija kod njih 0,5%, dakle manje često, ali s većom učestalošću nego kod placeba.
English: Approximately 33 % of patients in the irbesartan group reached the primary renal composite endpoint compared to 39 % and 41 % in the placebo and amlodipine groups [20 % relative risk reduction versus placebo (p = 0.024) and 23 % relative risk reduction compared to amlodipine (p = 0.006)].
Croatian: u placebo i 41% u amlodipin skupini [20% smanjenje relativnog rizika u odnosu na placebo (p=0,024) i 23% smanjenje relativnog rizika u usporedbi s amplodipinom (p=0,006)].
English: Irbesartan exhibits linear and dose proportional pharmacokinetics over the dose range of 10 to 600 mg. A less than proportional increase in oral absorption at doses beyond 600 mg (twice the maximal recommended dose) was observed; the mechanism for this is unknown.
Croatian: Zabilježen je neproporcionalan porast u oralnoj apsorpciji pri dozama većima od 600 mg (doza dvostruko veća od maksimalne preporučene doze): mehanizam za ovo je nepoznat.
English: The blood pressure lowering effect of irbesartan is evident within 1-2 weeks, with the maximal effect occurring by 4-6 weeks after start of therapy.
Croatian: Učinak irbesartana na snižavanje krvnog tlaka vidljiv je unutar 1-2 tjedna, s maksimalnim učinkom za
English: Patients with high blood pressure and type 2 diabetes with kidney disease
Croatian: Bolesnici s visokim krvnim tlakom i šećernom bolešću tipa 2 te bolešću bubrega
English: Clinical trial data has shown that dual blockade of the renin-angiotensin-aldosterone-system (RAAS) through the combined use of ACE-inhibitors, angiotensin II receptor blockers or aliskiren is associated with a higher frequency of adverse events such as hypotension, hyperkalaemia and decreased renal function (including acute renal failure) compared to the use of a single RAAS-acting agent (see sections 4.3, 4.4 and 5.1).
Croatian: Podaci iz kliničkih ispitivanja pokazali su da je dvostruka blokada renin-angiotenzin-aldosteronskog sustava (RAAS) kombiniranom primjenom ACE inhibitora, blokatora angiotenzin II receptora ili aliskirena povezana s većom učestalošću štetnih događaja kao što su hipotenzija, hiperkalemija i smanjena bubrežna funkcija (uključujući akutno zatajenje bubrega) u usporedbi s primjenom samo jednog lijeka koji djeluje na RAAS (vidjeti dijelove 4.3, 4.4 i 5.1)
English: In clinical studies, the pharmacokinetic of irbesartan is not affected by hydrochlorothiazide.
Croatian: U kliničkim ispitivanjima hidroklorotiazid nije utjecao na farmakokinetiku irbesartana.
English: D. CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT
Croatian: D. UVJETI ILI OGRANIČENJA VEZANI UZ SIGURNU I UČINKOVITU PRIMJENU
English: No dose adjustment is necessary in patients with impaired renal function.
Croatian: Nije potrebna prilagodba doze u bolesnika s oštećenom funkcijom bubrega.
English: If you are more than 3 months pregnant (It is also better to avoid Irbesartan Teva in early pregnancy - see pregnancy section).
Croatian: ako ste trudni više od 3 mjeseca (također se preporučuje izbjegavati Irbesartan Teva i u ranoj trudnoći - vidjeti dio o trudnoći).
English: When pregnancy is diagnosed, treatment with AIIRAs should be stopped immediately, and, if appropriate, alternative therapy should be started (see sections 4.3 and 4.6).
Croatian: II te treba, ako je to primjereno, započeti s alternativnom terapijom (vidjeti dijelove 4.3. i 4.6.).
English: At the end of the three weeks the mean reduction from baseline in the primary efficacy variable, trough seated systolic blood pressure (SeSBP) was 11.7 mm Hg (low dose), 9.3 mm Hg (medium dose), 13.2 mm Hg (high dose).
Croatian: Nakon tri tjedna srednja vrijednost smanjenja krvnog tlaka u odnosu na početne vrijednosti za primarnu varijablu djelotvornosti, sistolički krvni tlak u sjedećem položaju kod najniže koncentracije u krvi (engl. seated systolic blood pressure, SeSBP), iznosila je 11,7 mmHg (niska doza), 9,3 mmHg (srednja doza) i 13,2 mmHg (visoka doza).
English: Teva Pharma Belgium N.V./S.A/AG Tél/Tel: +32 38207373
Croatian: België/Belgique/Belgien Teva Pharma Belgium N.V./S.A/AG Tél/Tel: +32 38207373
English: In diabetic hypertensive patients with chronic renal insufficiency and overt proteinuria, hyperkalaemia (≥ 5.5 mEq/L) occurred in 46.3 % of the patients in the irbesartan group and 26.3 % of the patients in the placebo group.
Croatian: U bolesnika sa šećernom bolesti koji su imali povišeni krvni tlak, kroničnu bubrežnu insuficijenciju i manifestnu proteinuriju, hiperkalijemija (≥ 5,5 mEq/L) se razvila u 46,3% bolesnika koji su primali irbesartan te u 26,3% bolesnika u placebo skupini.
English: In non-clinical safety studies, high doses of irbesartan (≥ 250 mg/kg/day in rats and ≥ 100 mg/kg/day in macaques) caused a reduction of red blood cell parameters (erythrocytes, haemoglobin, haematocrit).
Croatian: mg/kg/dan u štakora i ≥ 100 mg/kg/dan u makaki majmuna) uzrokovale su smanjenje parametara crvenih krvnih stanica (eritrocita, hemoglobina, hematokrita).
English: Teva Pharma Belgium N.V./S.A./AG Tél/Tel: +32 38207373
Croatian: Luxembourg/Luxemburg Teva Pharma Belgium N.V./S.A./AG Tél/Tel: +32 38207373
English: if you are more than 3 months pregnant (it is also better to avoid Irbesartan Teva in early pregnancy - see pregnancy section).
Croatian: ako ste trudni više od 3 mjeseca (preporučuje se, također, izbjegavati Irbesartan Teva i u ranoj trudnoći - vidjeti dio o trudnoći).
English: When angiotensin II antagonists are administered simultaneously with non-steroidal anti-inflammatory drugs (i.e. selective COX-2 inhibitors, acetylsalicylic acid (> 3 g/day) and non-selective NSAIDs), attenuation of the antihypertensive effect may occur.
Croatian: selektivnim inhibitorima COX2, acetilsalicilatnom kiselinom (> 3 g/dan) i neselektivnim NSAIL) moguć je oslabljeni antihipertenzivni učinak.
English: In patients insufficiently controlled with 150 mg once daily, the dose of irbesartan can be increased to 300 mg, or other anti-hypertensive agents can be added (see sections 4.3, 4.4, 4.5 and 5.1).
Croatian: U bolesnika u kojih se bolest ne može dostatno kontrolirati dozom od 150 mg jedanput na dan, doza irbesartana može se povećati na 300 mg ili se mogu dodati drugi antihipertenzivi (vidjeti dijelove 4.3,
English: There is an increased risk of severe hypotension and renal insufficiency when patients with bilateral renal artery stenosis or stenosis of the artery to a single functioning kidney are treated with medicinal products that affect the renin-angiotensin-aldosterone system.
Croatian: Povećan je rizik od teške hipotenzije i insuficijencije bubrega u bolesnika koji se liječe lijekovima koji utječu na renin-angiotenzinski sustav, a imaju obostranu stenozu bubrežnih arterija ili stenozu arterije u jedinom funkcionalnom bubregu.
English: Microcrystalline cellulose Croscarmellose sodium Silica, colloidal hydrated Magnesium stearate
Croatian: celuloza, mikrokristalična karmelozanatrij, umrežena silicijev dioksid, koloidni, hidratizirani magnezijev stearat
English: No dose adjustment is necessary in patients with mild to moderate hepatic impairment.
Croatian: Nije potrebna prilagodba doze u bolesnika s blagim do umjerenim oštećenjem funkcije jetre.
English: 590 patients with type 2 diabetes, microalbuminuria (30-300 mg/day) and normal renal function (serum creatinine ≤ 1.5 mg/dl in males and < 1.1 mg/dl in females).
Croatian: IRMA 2 bila je placebom kontrolirana, dvostruko-slijepa studija morbiditeta u 590 bolesnika sa šećernom bolesti tipa 2, mikroalbuminurijom (30-300 mg/dan) i normalnom bubrežnom funkcijom (serumski kreatinin ≤ 1,5 mg/dl u muškaraca i < 1,1 mg/dl u žena).
English: In patients with high blood pressure and type 2 diabetes, 300 mg once daily is the preferred maintenance dose for the treatment of associated kidney disease.
Croatian: U bolesnika koji imaju visoki krvni tlak i boluju od šećerne bolesti tipa 2 preporučena doza održavanja za liječenje pridružene bolesti bubrega iznosi 300 mg jedanput na dan.
English: vertigo, headache Ear and labyrinth disorder Not known:
Croatian: Nepoznato: vrtoglavica, glavobolja Poremećaji uha i labirinta Nepoznato:
English: Irbesartan Teva slows the decrease of kidney function in patients with high blood pressure and type 2 diabetes.
Croatian: Irbesartan Teva usporava slabljenje bubrežne funkcije u bolesnika koji imaju povišen krvni tlak i boluju od šećerne bolesti tipa 2.
English: Hypertensive patients with type 2 diabetes and renal disease The effects of irbesartan both on renal and cardiovascular events were not uniform across all subgroups, in an analysis carried out in the study with patients with advanced renal disease.
Croatian: Učinak irbesartana na događaje povezane s bubrezima i kardiovaskularnim sustavom nije bio ujednačen u svim podskupinama u analizi rezultata kliničkih ispitivanja bolesnika s uznapredovalom bubrežnom bolesti.
English: Diabetes Mellitus (IRMA 2)” shows that irbesartan 300 mg delays progression to overt proteinuria in patients with microalbuminuria.
Croatian: Klinička studija „Učinak irbesartana na mikroalbuminuriju u hipertenzivnih bolesnika sa šećernom bolesti tipa 2 (IRMA 2)“ pokazuje da 300 mg irbesartana odgađa progresiju izražene proteinurije u bolesnika s mikroalbuminurijom.
English: No dosage adjustment is necessary in female patients.
Croatian: Stoga, nije potrebna prilagodba doziranja u žena.
English: Common (may affect up to 1in 10 people): dizziness, feeling sick/vomiting, fatigue and blood tests may show raised levels of an enzyme that measures the muscle and heart function (creatine kinase enzyme).
Croatian: Često (mogu se javiti u manje od 1 na 10 osoba): omaglica, mučnina/povraćanje, umor i krvne pretrage mogu pokazati povišenu razinu enzima specifičnog za mišićnu i srčanu funkciju (enzim kreatinin kinaza).
English: Additional antihypertensive agents (excluding ACE inhibitors, angiotensin II receptor antagonists and dihydropyridine calcium blockers) were added as needed to help achieve the blood pressure goal.
Croatian: Dodatni antihipertenzivi (isključujući ACE inhibitore, antagoniste receptora angiotenzina II i dihidropiridinske blokatore kalcijevih kanala)
English: In the female and black subgroups which represented 32 % and 26 % of the overall study population respectively, a renal benefit was not evident, although the confidence intervals do not exclude it. As for the secondary endpoint of fatal and non-fatal cardiovascular events, there was no difference among the three groups in the overall population, although an increased incidence of non-fatal MI was seen for women and a decreased incidence of non-fatal MI was seen in males in the irbesartan group versus the placebobased regimen.
Croatian: Za sekundarni studijski ishod fatalnih i nefatalnih kardiovaskularnih događaja, u sveukupnoj ispitivanoj populaciji nije bilo razlika između tri skupine, iako je zabilježena povećana incidencija nefatalnog infarkta miokarda u žena i smanjena incidencija nefatalnog infarkta miokarda u muškaraca u skupini koja je primala irbesartan u odnosu na onu koja je primala placebo.
English: Exposure to AIIRAs therapy during the second and third trimesters is known to induce human foetotoxicity (decreased renal function, oligohydramnios, skull ossification retardation) and neonatal toxicity (renal failure, hypotension, hyperkalaemia).
Croatian: Poznato je da u ljudi terapija antagonistima receptora angiotenzina II tijekom drugog i trećeg tromjesečja izaziva fetotoksičnost (smanjena bubrežna funkcija, oligohidramnion, usporavanje okoštavanja lubanje) i neonatalnu toksičnost (zatajenje bubrega, hipotenzija, hiperkalijemija) (vidjeti dio 5.3.).
English: White to off white capsule shaped, film coated tablet.
Croatian: Bijela do gotovo bijela, filmom obložena tableta u obliku kapsule.
English: Irbesartan Teva is available in pack sizes of 7, 14, 28, 30, 56, 60, 80, 84, 90, 98 and 100 film-coated tablets in non-perforated blisters; pack sizes of 50 x 1 and 56 x 1 film-coated tablet in unit dose blisters and pack size of 28 film-coated tablets in non-perforated calendar blisters.
Croatian: Irbesartan Teva dostupan je u pakiranjima sa 7, 14, 28, 30, 56, 60, 80, 84, 90, 98 i 100 filmom obloženih tableta u neperforiranim blisterima; pakovanjima sa 50 x 1 i 56 x 1 filmom obloženom tabletom u blisterima djeljivim na jedinične doze i pakiranju sa 28 filmom obloženih tableta u neperforiranim kalendarskim blisterima.
English: The demonstration of renal benefit of irbesartan in hypertensive type 2 diabetic patients is based on studies where irbesartan was used in addition to other antihypertensive agents, as needed, to reach target blood pressure (see sections 4.3, 4.4, 4.5 and 5.1).
Croatian: zasniva se na ispitivanjima u kojima se irbesartan prema potrebi uzimao kao dopuna ostaloj antihipertenzivnoj terapiji za postizanje ciljnog krvnog tlaka (vidjeti dijelove 4.3, 4.4, 4.5 i 5.1).
English: if you get excessive vomiting or diarrhoea if you suffer from kidney problems if you suffer from heart problems if you receive Irbesartan Teva for diabetic kidney disease.
Croatian: Obratite se svom liječniku prije nego uzmete Irbesartan Teva i ako se nešto od dolje navedenog odnosi na Vas: ako Vas muči prekomjerno povraćanje ili proljev ako imate problema s bubrezima ako imate srčanih problema ako uzimate Irbesartan Teva zbog dijabetičke bolesti bubrega.
English: The usual dose is 150 mg once a day.
Croatian: Bolesnici s visokim krvnim tlakom Uobičajena doza iznosi 150 mg jednom na dan.
English: The use of AIIRAs is contraindicated during the second and third trimesters of pregnancy (see sections 4.3 and 4.4).
Croatian: Uzimanje antagonista receptora angiotenzina II ne preporučuje se tijekom prvog tromjesečja trudnoće (vidjeti dio 4.4.), a kontraindicirana je tijekom drugog i trećeg tromjesečja (vidjeti dio 4.3. i 4.4.).
English: Not known: impaired renal function including cases of renal failure in patients at risk (see section 4.4) Reproductive system and breast disorders
Croatian: oštećena funkcija bubrega, uključujući slučajeve zatajenja bubrega u rizičnoj skupini bolesnika (vidjeti dio 4.4).
English: Unless continued AIIRAs therapy is considered essential, patients planning pregnancy should be changed to alternative anti-hypertensive treatments which have an established safety profile for use in pregnancy.
Croatian: Osim ako se nastavak terapije antagonistima receptora angiotenzina II ne smatra neophodnim, bolesnice koje planiraju trudnoću trebaju prijeći na alternativnu antihipertenzivnu terapiju s potvrđenom sigurnošću primjene u trudnoći.
English: Irbesartan Teva 150 mg film-coated tablets EU/1/09/576/014 7 tablets
Croatian: Irbesartan Teva 150 mg filmom obložene tablete EU/1/09/576/014 7 tableta
English: The efficacy of irbesartan is not influenced by age or gender.
Croatian: Dob i spol ne utječu na djelotvornost irbesartana.
English: if you are taking any of the following medicines used to treat high blood pressure: - an ACE-inhibitor (for example enalapril, lisinopril, ramipril), in particular if you have diabetes-related kidney problems - aliskiren
Croatian: ako uzimate bilo koji od lijekova navedenih u nastavku, koji se koriste za liječenje visokog krvnog tlaka: - blokator angiotenzin II receptora (ARB) (nazivaju se i sartanima - primjerice valsartan, telmisartan, irbesartan), osobito ako imate bubrežne tegobe povezane sa šećernom bolešću
English: Irbesartan Teva 75 mg film-coated tablets EU/1/09/576/001 7 tablets
Croatian: Irbesartan Teva 75 mg filmom obložene tablete EU/1/09/576/001 7 tableta
English: Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with angiotensin converting enzyme inhibitors.
Croatian: Tijekom istodobne primjene litija i inhibitora angiotenzin konvertirajućeg enzima zabilježen je reverzibilan porast koncentracije serumskog litija i njegove toksičnosti.
English: Studies have not been performed in patients with severe hepatic impairment.
Croatian: Nisu provođena ispitivanja kod bolesnika s teškim oštećenjem funkcije jetre.
English: The study of the “Effects of Irbesartan on Microalbuminuria in Hypertensive Patients with type 2
Croatian: Dokaz koristi irbesartana na bubrežnu funkciju u hipertenzivnih bolesnika sa šećernom bolesti tipa 2
English: • Each Irbesartan Teva 75 mg film-coated tablet contains 75 mg irbesartan.
Croatian: • Jedna Irbesartan Teva 75 mg filmom obložena tableta sadrži 75 mg irbesartana.
English: In 1.7 % of hypertensive patients with advanced diabetic renal disease treated with irbesartan, a decrease in haemoglobin*, which was not clinically significant, has been observed.
Croatian: Smanjenje razine hemoglobina*, koje nije bilo klinički značajno, zabilježeno je u 1,7% hipertenzivnih bolesnika s uznapredovalom dijabetičkom bubrežnom bolesti koji su primali irbesartan.
English: The decrease in blood pressure is dose-related for once a day doses with a tendency towards plateau at doses above 300 mg. Doses of 150-300 mg once daily lower supine or seated blood pressures at trough (i.e. 24 hours after dosing) by an average of 8-13/5-8 mm Hg (systolic/diastolic) greater than those associated with placebo.
Croatian: 150-300 mg jedanput na dan smanjuju krvni tlak u ležećem ili sjedećem položaju u vrijeme najniže koncentracije u krvi (to jest 24 sata nakon uzimanja doze) i to u prosjeku za 8-13/5-8 mm Hg
English: • Each Irbesartan Teva 150 mg film-coated tablet contains 150 mg irbesartan.
Croatian: • Jedna Irbesartan Teva 150 mg filmom obložena tableta sadrži 150 mg irbesartana.
English: Teva UK Limited Tel: +44 1977628500
Croatian: Tel: +44 1977628500
English: However, initiation of therapy with 75 mg could be considered, particularly in haemodialysed patients and in the elderly over 75 years.
Croatian: Međutim, u hemodijaliziranih bolesnika i u bolesnika starijih od 75 godina može se razmotriti započinjanje terapije dozom od 75 mg.
English: Hepatic impairment
Croatian: anafilaktički šok
English: After either oral or IV administration of 14C irbesartan, about 20 % of the radioactivity is recovered in the urine, and the remainder in the faeces.
Croatian: irbesartana, oko 20% radioaktivnosti pojavilo se u mokraći, a ostatak u stolici.
English: • Each Irbesartan Teva 300 mg film-coated tablet contains 300 mg irbesartan.
Croatian: • Jedna Irbesartan Teva 300 mg filmom obložena tableta sadrži 300 mg irbesartana.
English: The other side of the tablet debossed with number “7466”.
Croatian: Na drugoj strani tablete je utisnut broj “7466”.
English: The other side of the tablet debossed with number “7464”.
Croatian: Na drugoj strani tablete je utisnut broj "7464".
English: nausea/vomiting
Croatian: proljeva ili povraćanja.
English: Irbesartan 150 mg film-coated tablets are white to off white capsule shaped, film coated tablet.
Croatian: Irbesartan Teva 150 mg filmom obložene tablete Bijela do gotovo bijela, filmom obložena tableta u obliku kapsule.
English: IRMA 2 was a placebo-controlled double blind morbidity study in
Croatian: IDNT je bila dvostruko slijepa,
English: Hypertension and type 2 diabetes with renal disease
Croatian: Hipertenzivni bolesnici sa šećernom bolesti tipa 2 i bubrežnom bolesti
English: Package leaflet: information for the user Irbesartan Teva 75 mg Film-Coated Tablets
Croatian: Uputa o lijeku: Informacija za korisnika Irbesartan Teva 75 mg filmom obložene tablete irbesartan
English: Experience in adults exposed to doses of up to 900 mg/day for 8 weeks revealed no toxicity.
Croatian: 4.9 Predoziranje Iskustvo je pokazalo da nije bilo toksičnog djelovanja irbesartana u odraslih ljudi koji su bili izloženi dozama do 900 mg/dan tijekom 8 tjedana.
English: You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Croatian: Nuspojave možete prijaviti izravno putem nacionalnog sustava prijave nuspojava: navedenog u Dodatku V*..
English: Irbesartan Teva 75 mg film-coated tablets
Croatian: Irbesartan Teva 75 mg filmom obložene tablete
English: A lower starting dose (75 mg) should be considered for patients undergoing haemodialysis (see section 4.4).
Croatian: U bolesnika na hemodijalizi treba razmotriti započinjanje liječenja nižom početnom dozom od 75 mg (vidjeti dio
English: Package leaflet: information for the user Irbesartan Teva 300 mg Film-Coated Tablets
Croatian: Uputa o lijeku: Informacija za korisnika Irbesartan Teva 300 mg filmom obložene tablete irbesartan
English: The other side of the tablet debossed with number “7465”.
Croatian: Na drugoj strani tablete je utisnut broj “7465”.
English: Irbesartan Teva 75 mg film-coated tablets Each film-coated tablet contains 75 mg of irbesartan
Croatian: Irbesartan Teva 75 mg filmom obložene tablete Jedna filmom obložena tableta sadrži 75 mg irbesartana
English: Package leaflet: information for the user Irbesartan Teva 150 mg Film-Coated Tablets
Croatian: Uputa o lijeku: Informacija za korisnika Irbesartan Teva 150 mg filmom obložene tablete irbesartan
English: Irbesartan Teva 150 mg film-coated tablets Each film-coated tablet contains 150 mg of irbesartan
Croatian: Irbesartan Teva 150 mg filmom obložene tablete Jedna filmom obložena tableta sadrži 150 mg irbesartana
English: Subgroups consisting of gender, race, age, duration of diabetes, baseline blood pressure, serum creatinine, and albumin excretion rate were assessed for treatment effect.
Croatian: Za djelotvornost liječenja ocjenjivane su podskupine prema spolu, rasi, dobi, trajanju šećerne bolesti, početnom krvnom tlaku, serumskom kreatininu i izlučivanju albumina.U podskupinama žena i pripadnika crne rase, koji su činili 32% odnosno 26% ukupne populacije u studiji, nisu bili vidljivi povoljni učinci na bubrege, premda to intervali pouzdanosti nisu isključivali.
English: Irbesartan Teva 75 mg film-coated tablets Irbesartan
Croatian: Irbesartan Teva 75 mg filmom obložene tablete irbesartan
English: The “Irbesartan Diabetic Nephropathy Trial (IDNT)” shows that irbesartan decreases the progression of renal disease in patients with chronic renal insufficiency and overt proteinuria.
Croatian: Hipertenzija i šećerna bolest tipa 2 s bubrežnom bolesti Klinička studija „Ispitivanje irbesartana u bolesnika s dijabetičkom nefropatijom“ (Irbesartan Diabetic Nephropathy Trial, IDNT) pokazuje da irbesartan smanjuje progresiju bubrežne bolesti u bolesnika s kroničnom bubrežnom insuficijencijom i manifestnom proteinurijom.
English: If you take more Irbesartan Teva than you should
Croatian: Ako uzmete više Irbesartana
English: Irbesartan Teva 300 mg film-coated tablets Each film-coated tablet contains 300 mg of irbesartan
Croatian: Irbesartan Teva 300 mg filmom obložene tablete Jedna filmom obložena tableta sadrži 300 mg irbesartana
English: Irbesartan Teva 300 mg film-coated tablets EU/1/09/576/027 7 tablets EU/1/09/576/028 14 tablets
Croatian: Irbesartan Teva 300 mg filmom obložene tablete EU/1/09/576/027 7 tableta
English: Cardiac disorders Uncommon: tachycardia Vascular disorders Common:
Croatian: Srčani poremećaji Manje često: tahikardija Krvožilni poremećaji Često: ortostatska hipotenzija*
English: If you are taking an ACE-inhibitor or aliskiren (see also information under the headings “Do not take Irbesartan Teva” and “Warnings and precautions”).
Croatian: “Nemojte uzimati Irbesartan Teva” i “Upozorenja i mjere opreza”).
English: Patients in all treatment groups typically received between 2 and 4 antihypertensive agents (e.g., diuretics, beta blockers, alpha blockers) to reach a predefined blood pressure goal of ≤ 135/85 mm Hg or a 10 mm Hg reduction in systolic pressure if baseline was > 160 mm Hg.
Croatian: diuretike, beta blokatore, alfa blokatore) kako bi postigli unaprijed definirani krvni tlak od ≤ 135/85